research funding database


Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)

Share this post

Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange plus symbol appears between the two logos.

The Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed) funding program from the National Institutes of Health (NIH) supports high-risk, high-impact, early discovery research on vaccine approaches to prevent the acquisition of or ongoing infection by HIV. In keeping with the high-risk, high-impact nature of this research, this program supports a Go/No-Go approach to funding high-risk research, which is significantly different from most R01 projects. Continued funding for the full award duration is dependent upon achieving negotiated Go/No-Go criteria by the end of Year 2. Applications are open to researchers in the USA and worldwide. Applicants may apply for up to 350,000 USD/year for up to 4 years.

Opportunity ID: PAR-23-169.

Full applications are due August 2, 2024.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for our monthly
research funding newsletter

you can unsubscribe at any time

Be the first to know

Sign-up for Personalized Grant Alerts